Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Iniparib (BSI-201) (BSI-201) , a PARP1 inhibitor, exhibits potency in triple-negative breast Y (TNBC).
説明 | Iniparib (BSI-201) (BSI-201) , a PARP1 inhibitor, exhibits potency in triple-negative breast Y (TNBC). |
細胞研究 | Cells are exposed to various concentrations of BSI-201 for 5, and 9 days in the presence or absence of buthionine sulfoxamide (BSO). After treatment, cell proliferation is measured by CellTiter-Glo assay.(Only for Reference) |
別名 | NSC-746045, IND-71677, BSI-201 |
分子量 | 292.03 |
分子式 | C7H5IN2O3 |
CAS No. | 160003-66-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ethanol: 14.6 mg/mL (50 mM)
DMSO: 14.6 mg/mL (50 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Iniparib 160003-66-7 Chromatin/Epigenetic DNA Damage/DNA Repair Microbiology/Virology PARP Influenza Virus NSC-746045 Inhibitor BSI201 inhibit BSI 201 IND-71677 NSC 746045 IND 71677 NSC746045 IND71677 poly ADP ribose polymerase BSI-201 inhibitor